Ticker Symbol: PMVP
PMV Pharmaceuticals Inc
$25.66 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001699382
Company Profile
PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants. p53 mutations are found in approximately half of all cancers. The field of p53 biology was established by our co-founder Dr. Arnold Levine when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize over four decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus. PMV Pharma is headquartered in Cranbury, New Jersey.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: pmvpharma.com
CEO: N/A
Tags:
- Commercial Services
- Miscellaneous Commercial Services
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $2.00
Change:
-$0.49
(
-19.68%)
Days Range: $1.69 - $2.49
Beta: 1.50
52wk. High: $13.02
52wk. Low: $1.47
Ytd. Change -96.69%
50 Day Moving Average: $5.36
200 Day Moving Average: $5.87
Shares Outstanding: 48454582
Valuation
Market Cap: 9.7B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A